GMRE Stock Analysis: Buy, Sell, or Hold?
GMRE - Global Medical REIT Inc.
$34.54
0.30 (0.88%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When GMRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GMRE shows positive signals but monitor for confirmation. Market pricing in 32.6% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: GMRE shows positive signals but monitor for confirmation. Market pricing in 32.6% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GMRE is currently trading at $34.54, which is considered fair relative to its 30-day fair value range of $33.76 to $35.61. From a valuation perspective, the stock is trading at a premium (Forward PE: 285.3) compared to its historical average (122.5). At these levels, the market is pricing in 32.6% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GMRE is in a uptrend. The price is currently testing key support at $33.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.25 (+17.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GMRE is in a uptrend. The price is currently testing key support at $33.79. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.25 (+17.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$33.76 -
$35.61
Company Quality Score
50/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
70.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($40.25)
- NEUTRAL: PE elevated vs history but 32.6% growth expectation is conservative given 200% recent growth
Fair Price Analysis
30-Day Fair Range
$33.76 -
$35.61
Current vs Fair Value
FAIR
Expected Move (7 Days)
±$1.53
(4.4%)
Support & Resistance Levels
Support Level
$33.79
Resistance Level
$36.49
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
285.33
Wall Street Target
$40.25
(+17.6%)
Revenue Growth (YoY)
8.6%
Earnings Growth (YoY)
200.0%
Profit Margin
1.7%
Valuation Premium vs History
+32.6% premium
PE vs Historical
285.3 vs 122.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+32.6%
(market-implied from PE analysis)
1-Year Target
$45.40
(+33%)
2-Year Target
$60.20
(+76%)
3-Year Target
$79.83
(+133%)
3-Yr Target (if PE normalizes)
(PE: 285→123)
PE COMPRESSION
$34.27
(+0%)
Earnings growth offset by PE compression
Last updated: January 31, 2026 3:31 AM ET
Data refreshes hourly during market hours. Next update: 4:31 AM
Data refreshes hourly during market hours. Next update: 4:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GMRE showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Matthew Cypher
BUY
270 shares
2025-08-26
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$86 | 59 HOLD |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$209 | 62 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 54 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$14 | 57 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$56 | 54 HOLD |
Advanced GMRE Option Strategies
Professional options setups generated by AI based on today's GMRE price and gamma walls.
